Skip to main content
. 2015 Aug 14;15:103. doi: 10.1186/s12876-015-0333-z

Fig. 2.

Fig. 2

Receiver operating characteristic graphs to assess the significance of C-reactive protein (week 2/week 0) ratio for the prediction of infliximab partial-responder in patients with active ulcerative colitis undergoing infliximab-induction therapy. A cut-off value of 0.19 for C-reactive protein ratio on the receiver operating characteristic graph could predict infliximab partial-responder feature with a 79.1 % sensitivity and 75.9 % specificity